QA: GlobeStar Therapeutics Corp in us_pharma/2017

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001502152_2018_GlobeStar_Therapeutics_Corp.pdf

Logs

warning Missing logo subcommand.report {}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0001502152')"}

Graph

Absolute values for 0001502152, GlobeStar Therapeutics Corp

  xvar xval
0 AssetsCurrent 14,850
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 9,703
4 LiabilitiesCurrent 504,855
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 143,673
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 460,909
9 ResearchAndDevelopmentExpense 0
10 remainder_Expenses 635,685
11 remainder_Revenues 0
12 remainder_NetIncome -583,195
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 24,553
1 Liabilities 648,528
2 Expenses 1,096,594
3 Revenues 0
4 StockholdersEquity -623,975
5 NetIncome -1,679,789
6 ComprehensiveNetIncome -1,679,789
7 BaseVar 1,176,435
8 EconomicCapitalRatio -8.18

Edgar->Model Mapping

Feature Distribution

Change over Time